Schonfeld Strategic Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-244,620
| Closed | -$3.65M | – | 2165 |
|
|
2023
Q3 | $3.65M | Buy |
244,620
+173,938
| +246% | +$2.59M | 0.03% | 545 |
|
|
2023
Q2 | $774K | Buy |
+70,682
| New | +$774K | 0.01% | 1047 |
|
|
2023
Q1 | – | Sell |
-121,683
| Closed | -$763K | – | 2698 |
|
|
2022
Q4 | $763K | Buy |
+121,683
| New | +$763K | 0.01% | 1288 |
|
|
2021
Q3 | – | Sell |
-15,003
| Closed | -$65K | – | 2411 |
|
|
2021
Q2 | $65K | Buy |
+15,003
| New | +$65K | ﹤0.01% | 1817 |
|
|
2020
Q4 | – | Sell |
-501,368
| Closed | -$3.63M | – | 1890 |
|
|
2020
Q3 | $3.63M | Buy |
501,368
+420,986
| +524% | +$3.05M | 0.07% | 342 |
|
|
2020
Q2 | $281K | Buy |
80,382
+24,132
| +43% | +$84.4K | 0.01% | 974 |
|
|
2020
Q1 | $83K | Buy |
+56,250
| New | +$83K | 0.01% | 1022 |
|
|
2019
Q4 | – | Sell |
-77,800
| Closed | -$398K | – | 1503 |
|
|
2019
Q3 | $398K | Sell |
77,800
-494,400
| -86% | -$2.53M | 0.01% | 709 |
|
|
2019
Q2 | $4.1M | Buy |
572,200
+268,800
| +89% | +$1.92M | 0.14% | 172 |
|
|
2019
Q1 | $4.03M | Buy |
303,400
+281,200
| +1,267% | +$3.73M | 0.14% | 194 |
|
|
2018
Q4 | $175K | Buy |
22,200
+8,200
| +59% | +$64.6K | 0.01% | 962 |
|
|
2018
Q3 | $156K | Sell |
14,000
-12,000
| -46% | -$134K | 0.01% | 758 |
|
|
2018
Q2 | $349K | Buy |
+26,000
| New | +$349K | 0.02% | 604 |
|
|
2017
Q4 | – | Sell |
-34,410
| Closed | -$278K | – | 892 |
|
|
2017
Q3 | $278K | Buy |
+34,410
| New | +$278K | 0.03% | 468 |
|